|
Pharmacom® µ-C1 |
Monitor
earlier stage breast cancer |
|
Pharmacom® µ-C2 |
Monitor
earlier stage ovarian
cancer |
|
Pharmacom® µ-C3 |
Monitor
earlier stage prostate
cancer |
|
Pharmacom® µ-C4 |
Monitor
earlier stage brain tumor |
|
Pharmacom® µ-C5 |
Monitor
earlier stage leukaemia |
|
Pharmacom® µ-C6 |
Monitor for genetic predisposition
to GI-relevant diseases |